147 related articles for article (PubMed ID: 33243034)
21. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
22. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
Wolter NE; Ngan B; Whitlock JA; Dickson BC; Propst EJ
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109585. PubMed ID: 31351348
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.
Reinhart S; Trachsel Y; Fritz C; Wagner U; Bode-Lesniewska B; John H; Pless M
Urology; 2020 Dec; 146():32-35. PubMed ID: 33007314
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
25. Intraarticular Inflammatory Myofibroblastic Tumor of the Left Knee With ALK-CARS Fusion Detected With Archer Fusionplex Sarcoma NGS Panel: Case Report and Literature Review.
Pineda-Díaz J; Solar I; Hershkovitz D; Drukman I; Sher O
Int J Surg Pathol; 2021 Apr; 29(2):216-222. PubMed ID: 32631118
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
27. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.
Bai Y; Sun W; Niu D; Yang X; Diao X; Yu Y; Lin D
Virchows Arch; 2021 Dec; 479(6):1079-1083. PubMed ID: 33825946
[TBL] [Abstract][Full Text] [Related]
28. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
[TBL] [Abstract][Full Text] [Related]
29. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
[TBL] [Abstract][Full Text] [Related]
30. A Novel ALK-THBS1 Fusion in a Laryngeal Inflammatory Myofibroblastic Tumour: A Case Report and Literature Review.
Elktaibi A; Benzerdjeb N; Ameur F; Daveau C; Tantot J; Costes Martineau V
Head Neck Pathol; 2020 Jun; 14(2):454-458. PubMed ID: 31368077
[TBL] [Abstract][Full Text] [Related]
31. A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.
Miyagawa C; Takaya H; Sakai K; Nishio K; Konishi M; Minamiguchi S; Shimada T; Matsumura N
Oncologist; 2021 May; 26(5):356-361. PubMed ID: 33555117
[TBL] [Abstract][Full Text] [Related]
32. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib.
Sunga CGG; Higgins MS; Ricciotti RW; Liu YJ; Cranmer LD
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1792. PubMed ID: 36754839
[TBL] [Abstract][Full Text] [Related]
34. ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report.
Swain F; Williams B; Barbaro P
Acta Haematol; 2021; 144(2):218-221. PubMed ID: 32721959
[TBL] [Abstract][Full Text] [Related]
35. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.
Chan JK; Lamant L; Algar E; Delsol G; Tsang WY; Lee KC; Tiedemann K; Chow CW
Blood; 2008 Oct; 112(7):2965-8. PubMed ID: 18660380
[TBL] [Abstract][Full Text] [Related]
36. Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively.
Tao H; Liu Z; Mu J; Gai F; Huang Z; Shi L
Diagn Pathol; 2022 Feb; 17(1):27. PubMed ID: 35144623
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory Myofibroblastic Tumor Driven by Novel
Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
[TBL] [Abstract][Full Text] [Related]
38. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
Zhou Y; Hurtado-Castillo M; Pandey O
Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
[TBL] [Abstract][Full Text] [Related]
39. A Rare Case of Tracheal Crystal-Storing Histiocytosis Associated with Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
Kimura S; Oyama Y; Ziyao W; Waseda R; Nishino N; Sakata T; Takeshita M
Int J Surg Pathol; 2022 Aug; 30(5):543-550. PubMed ID: 35075931
[TBL] [Abstract][Full Text] [Related]
40. Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review.
Li M; An Z; Tang Q; Ma Y; Yan J; Chen S; Wang Y
J Cell Mol Med; 2021 Oct; 25(19):9476-9481. PubMed ID: 34541785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
